Page last updated: 2024-10-16

adenine and Hepatitis E

adenine has been researched along with Hepatitis E in 3 studies

Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Research Excerpts

ExcerptRelevanceReference
"In areas where chronic hepatitis B virus infection is prevalent, acute hepatitis E virus superinfection on chronic hepatitis B virus infection occurs sporadically."1.48Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report. ( Chiang, YJ; Chu, YD; Yeh, CS; Yeh, CT, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yeh, CT1
Yeh, CS1
Chu, YD1
Chiang, YJ1
Boudin, L1
Patient, M1
Tsitsi Nding Tsogou, P1
Roméo, E1
Bladé, JS1
de Jauréguiberry, JP1
Price, J1

Reviews

1 review available for adenine and Hepatitis E

ArticleYear
An update on hepatitis B, D, and E viruses.
    Topics in antiviral medicine, 2014, Volume: 21, Issue:5

    Topics: Adenine; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis E

2014

Other Studies

2 other studies available for adenine and Hepatitis E

ArticleYear
Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report.
    Journal of medical case reports, 2018, Feb-28, Volume: 12, Issue:1

    Topics: Adenine; Coinfection; Disease Progression; DNA, Viral; Female; Graft Rejection; Hepatitis B Surface

2018
Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib.
    Bulletin du cancer, 2019, Volume: 106, Issue:1

    Topics: Adenine; Aged; Alemtuzumab; Antineoplastic Agents, Immunological; Antiviral Agents; Chronic Disease;

2019